Skip to main content

Stavros G. Vizirgianakis

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stavros G. Vizirgianakis

Stavros G. Vizirgianakis is recorded as Chairman at Xtant Medical Holdings, Inc. (XTNT). Xtant Medical Holdings, Inc. reported in an 8-K filed November 10, 2025 that Stavros G. Vizirgianakis was appointed director, effective November 7, 2025. Xtant Medical Holdings, Inc. reported in an 8-K filed August 31, 2022 that Stavros G. Vizirgianakis was appointed Chairman of the Board. Xtant Medical Holdings, Inc. reported in an 8-K filed August 31, 2022 that Stavros G. Vizirgianakis was appointed member of the Board. Equibles holds 4 filed executive changes naming Stavros G. Vizirgianakis; each is listed under recent activity with its source filing.

“The six nominees proposed by the Company’s Board of Directors were elected to serve as directors until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified by the following final voting results:”
Xtant Medical Holdings, Inc. Form 8-K, filed November 10, 2025 · Read the filing
“The Board shall elect the Nominee to the position of Chairman of the Board effective upon completion of the First Closing and at each annual or special meeting of stockholders of the Company at which directors are elected thereafter, subject to Section 11 of this Letter Agreement.”
Xtant Medical Holdings, Inc. Form 8-K, filed August 31, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Xtant Medical Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.